MAPT and Alzheimer disease: Chronic DR reduced both Aβ and phospho-tau levels in hippocampus in the triple transgenic mouse model of AD, 3xTg mice expressing human APP KM670/671NL, TAU P301L, and PSEN1 M146V mutants with concomitant improvement in memory [129].